Hvis kombinationen alligevel anses for nødvendig, anbefales det kraftigt at monitorere plasmaniveauerne for disse proteasehæmmere.
If the combination is nevertheless considered necessary, a monitoring of the plasma levels of these protease inhibitors is strongly encouraged.